Abstract
According to estimations of the German Cancer Research Center in Heidelberg, the management of germ cell tumors in Germany is characterized by a marked difference between the actual mortality and the mortality to be expected with adequate implementation of the therapy standard. Our aim is to reduce the mortality rate by introducing a treatment procedure supported by a second opinion center.
MeSH terms
-
Cancer Care Facilities
-
Clinical Trials as Topic
-
Combined Modality Therapy
-
Evidence-Based Medicine
-
Germany
-
Humans
-
Male
-
Neoplasms, Germ Cell and Embryonal / diagnosis
-
Neoplasms, Germ Cell and Embryonal / mortality
-
Neoplasms, Germ Cell and Embryonal / therapy*
-
Patient Care Team
-
Practice Guidelines as Topic
-
Quality Assurance, Health Care*
-
Referral and Consultation*
-
Survival Rate
-
Testicular Neoplasms / diagnosis
-
Testicular Neoplasms / mortality
-
Testicular Neoplasms / therapy*